menu
    • menu

    Company profile for EdiGene

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Boya Gene was established in 2015 and currently has four platforms centered on gene editing technology, and is committed to promoting R&D projects for genetic diseases and tumors into the clinic. The four platforms include an in vitro cell gene editing therapy platform for hematopoietic stem cells and T cells, an in vivo gene editing therapy platform based on RNA single-base editing technology, and a high-throughput genome edi...
    Boya Gene was established in 2015 and currently has four platforms centered on gene editing technology, and is committed to promoting R&D projects for genetic diseases and tumors into the clinic. The four platforms include an in vitro cell gene editing therapy platform for hematopoietic stem cells and T cells, an in vivo gene editing therapy platform based on RNA single-base editing technology, and a high-throughput genome editing screening platform dedicated to targeted drug development. At the same time, Boya Gene has established a clinical transformation application base that meets GMP standards in Nansha District, Guangzhou in 2018 .

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EdiGeneChina Flag
    Country
    Country
    China
    Address
    Address
    Building 2, No. 22, Science Park Road, Zhongguancun Life Science Park, Changpi...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.edigene.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EdiGene to Unveil Promising Preclinical POC Data for LEAPER™ 2.0
    EdiGene to Unveil Promising Preclinical POC Data for LEAPER™ 2.0

    02 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230502005658/en

    BUSINESSWIRE
    02 May 2023
    Share Share
    EdiGene to Present Efficacy Results of an Investigator Initiated Trial for ET-01
    EdiGene to Present Efficacy Results of an Investigator Initiated Trial for ET-01

    03 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221103005624/en

    BUSINESSWIRE
    03 Nov 2022
    Share Share
    EdiGene Enters Research Collaboration With Peking University Cancer Hospital
    EdiGene Enters Research Collaboration With Peking University Cancer Hospital

    13 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220413005473/en

    BUSINESSWIRE
    13 Apr 2022
    Share Share
    EdiGene Obtains Worldwide License from Boston Children’s Hospital
    EdiGene Obtains Worldwide License from Boston Children’s Hospital

    15 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220316005444/en

    BUSINESSWIRE
    15 Mar 2022
    Share Share
    EdiGene, Neukio ink R&D collaboration to develop next-gen immune cell therapies
    EdiGene, Neukio ink R&D collaboration to develop next-gen immune cell therapies

    11 Feb 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=145778&sid=2

    PHARMABIZ
    11 Feb 2022
    Share Share
    EdiGene Announces Publication in Nature Biotechnology of LEAPER 2.0
    EdiGene Announces Publication in Nature Biotechnology of LEAPER 2.0

    10 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220210005778/en

    BUSINESSWIRE
    10 Feb 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search